Ego Elastomers Profile
Key Indicators
- Authorised Capital ₹ 1.10 Cr
as on 06-07-2024
- Paid Up Capital ₹ 2.61 M
as on 06-07-2024
- Company Age 32 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.30 M
as on 06-07-2024
- Revenue 998.63%
(FY 2022)
- Profit -62.38%
(FY 2022)
- Ebitda -16.65%
(FY 2022)
- Net Worth -61.95%
(FY 2022)
- Total Assets 147.62%
(FY 2022)
About Ego Elastomers
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.10 Cr and a paid-up capital of Rs 2.61 M.
The company has closed loans amounting to ₹6.30 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sandeep Kedia and Anju Sikaria serve as directors at the Company.
- CIN/LLPIN
U52100UR1992PTC014731
- Company No.
014731
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Sep 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ego Elastomers?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sandeep Kedia | Director | 01-Apr-2019 | Current |
Anju Sikaria | Director | 26-Oct-2018 | Current |
Financial Performance and Corporate Structure Insights of Ego Elastomers.
Ego Elastomers Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 998.63% increase. The company also saw a substantial fall in profitability, with a 62.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 61.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Ego Elastomers?
In 2021, Ego Elastomers had a promoter holding of 49.96% and a public holding of 50.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Shree Sagarmatha Properties Private LimitedActive 13 years 2 months
Sandeep Kedia is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Oriental Bank Of Commerce Creation Date: 26 Jul 2004 | ₹3.70 M | Satisfied |
Union Bank Of India Creation Date: 02 Jan 1999 | ₹2.20 M | Satisfied |
Union Bank Of India Creation Date: 24 Nov 1993 | ₹0.20 M | Satisfied |
How Many Employees Work at Ego Elastomers?
Unlock and access historical data on people associated with Ego Elastomers, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ego Elastomers, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ego Elastomers's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.